博雅生物：2025年半年度归属于上市公司股东的净利润为225340907.90元

Core Insights - The company reported a revenue of 1,007,772,869.56 yuan for the first half of 2025, reflecting a year-on-year growth of 12.51% [2] - The net profit attributable to shareholders decreased to 225,340,907.90 yuan, representing a year-on-year decline of 28.68% [2] Financial Performance - Revenue for the first half of 2025: 1,007.77 million yuan, up 12.51% compared to the previous year [2] - Net profit for the same period: 225.34 million yuan, down 28.68% year-on-year [2]